Abstract:Mumps virus is highly neurotropic, with evidence of infection of the central nervous system in more than half of clinical cases. In the prevaccine era, mumps was a major cause of viral meningitis in most developed countries. Despite efforts to attenuate the virus, some mumps vaccines have retained virulence properties and have caused aseptic meningitis in vaccinees, resulting in public resistance to vaccination in some countries. Ensuring the safety of mumps vaccines is an important public health objective, as the need for robust immunization programs has been made clear by the recent resurgence of mumps outbreaks worldwide, including the United States, which in 2006 experienced its largest mumps outbreak in 20 years. To better understand the molecular basis of mumps virus attenuation, the authors developed two infectious full-length cDNA clones for a highly neurovirulent strain of mumps virus. The clones differed at only one site, possessing either an A or G at nucleotide position 271 in the F gene, to represent the heterogeneity identified in the original virulent clinical isolate. In comparison to the clinical isolate, virus rescued from the A-variant cDNA clone grew to higher cumulative titers in vitro but exhibited similar cytopathic effects in vitro and virulence in vivo. In contrast, virus rescued from the G-variant cDNA clone, in comparison to the clinical isolate and the A-variant, was more fusogenic in vitro but replicated to lower cumulative titers and was less neurovirulent in vivo. These data suggest that nucleotide position 271 in the F gene plays a significant role in virus pathogenesis. This infectious clone system will serve as a key tool for further examination of the molecular basis for mumps virus neurovirulence and neuroattenuation.

Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype

Gene-specific contributions to mumps virus neurovirulence and neuroattenuation

Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity

A single nucleotide change in the mumps virus F gene affects virus fusogenicity in vitro and virulence in vivo

Functional consequences of attenuating mutations in the haemagglutinin neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain

Single amino acid changes in the mumps virus haemagglutinin-neuraminidase and polymerase proteins are associated with neuroattenuation

Identification of genetic mutations associated with attenuation and changes in tropism of Urabe mumps virus

Development of Improved Mumps Vaccine Candidates by Mutating Viral mRNA Cap Methyltransferase Sites in the Large Polymerase Protein

Characterization of mumps virus strains with varying neurovirulence

The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence

Genetic variation in the HN and SH genes of mumps viruses: a comparison of strains from mumps cases with and without neurological symptoms

Establishment of an Efficient Reverse Genetic System of Mumps Virus S79 from Cloned DNA

Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence

Neurovirulence safety testing of mumps vaccines--historical perspective and current status

Molecular biology, pathogenesis and pathology of mumps virus

A Single Point Mutation in the Mumps V Protein Alters Targeting of the Cellular STAT Pathways Resulting in Virus Attenuation

Immunogenicity of novel mumps vaccine candidates generated by genetic modification

Influence of population diversity on neurovirulence potential of plaque purified L-Zagreb variants

The molecular epidemiology of mumps virus

Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein

Discrimination of mumps virus small hydrophobic gene deletion effects from gene translation effects on virus virulence